Drug Shortage Report for MAVIK
| Report ID | 38488 |
| Drug Identification Number | 02239267 |
| Brand name | MAVIK |
| Common or Proper name | MAVIK |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TRANDOLAPRIL |
| Strength(s) | 4MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09AA |
| ATC description | ACE INHIBITORS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-06-21 |
| Actual start date | 2018-06-21 |
| Estimated end date | 2018-07-06 |
| Actual end date | 2018-06-27 |
| Shortage status | Resolved |
| Updated date | 2018-06-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.